|
MechanismTGF-β1 inhibitors |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
An open label, observational, non-interventional, unicentric, clinical investigation to evaluate the efficacy and safety of woman ISDIN Vaginal Moisturizer on symptomatic vaginal atrophy in 43 post menopausal woman during 12 weeks in the alleviation of vaginal atrophy symptoms
Clinical evaluation of a toothpaste formulation including cetyl pyridinium chloride and cymenol: safety, clinical efficacy and microbiological impact and patient perception
Evaluation of sun protective effect of a sunscreen product under outdoor conditions compared to SPF15, SPF30 and SPF50+. A randomized, double blind, intra-individual, single center clinical study in healthy subjects
100 Clinical Results associated with ISDIN SA
0 Patents (Medical) associated with ISDIN SA
100 Deals associated with ISDIN SA
100 Translational Medicine associated with ISDIN SA